ong-term pain modulation by intravenous esketamine in Complex Regional Pain Syndrome: a non-inferiority study

Center for Pain Medicine, Erasmus MC0 个研究点目标入组 60 人开始时间: 2021年8月3日最近更新: 2021年11月15日

适应症

试验速览

暂无简介。

•In order to be eligible to participate in this study, a subject must meet all of the following criteria:
•-Age = 18 years.
•-Meeting or having met the Budapest Criteria of CRPS (Harden, 2010)
•-Willing and capable to participate in the study.
•-CRPS in one upper extremity and/or CRPS in one lower extremity
•-Treatment in an elective setting.
•Are the trial subjects under 18? no
•Number of subjects for this age range:
•F.1.2 Adults (18-64 years) yes
•F.1.2.1 Number of subjects for this age range 60
•F.1.3 Elderly (>=65 years) no
•F.1.3.1 Number of subjects for this age range

•A potential subject who meets any of the following criteria will be excluded from participation in this study:
•-Inadequate comprehension of the Dutch language
•-Pregnancy
•-Unstable angina, poorly controlled hypertension, high-risk coronary vascular disease
•-Severe liver disease
•-Elevated intracranial pressure
•-Elevated intraocular pressure, acute globe injury, or glaucoma
•-Thyrotoxicosis
•-Pheochromocytoma
•-Active substance abuse
•-Psychosis or delirium
•-Refusal or inability to consent

发起方

Center for Pain Medicine, Erasmus MC